Insider Financial
Biotech
-
363Novocure Ltd (NASDAQ:NVCR) Is a Strong And Pertinent Biotech Play
Brain cancer, specifically glioblastoma multiforme (GBM) is very much a hot topic at the moment. With news hitting press that Senator McCain has...
-
473Pernix Therapeutics Holdings Inc (NASDAQ:PTX): Heading In The Right Direction
It’s only been a few days since we suggested Pernix Therapeutics Holdings Inc (NASDAQ:PTX) might be in line for a breakout. The...
-
613Can CymaBay Therapeutics Inc (NASDAQ:CBAY) Continue On Its Superb Run?
CymaBay Therapeutics Inc (NASDAQ:CBAY) has been one of the small cap biotechnology space’s most consistent performers during 2017 to date. The company...
-
602Novavax Inc (NASDAQ:NVAX) Is Finally Starting To Pay Off
Back in May this year we urged our readers to look beyond the share price with Novavax Inc (NASDAQ:NVAX) and weigh the...
-
811ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC): Here’s Our Take
ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) is not having a great week. The company just announced an offering that will see it issue a...
-
835Capricor Therapeutics Inc (NASDAQ:CAPR) Just Scored A Huge Potential Payday
Capricor Therapeutics Inc (NASDAQ:CAPR) ran up close to 100% during the session on Tuesday, closing out at $1.36 a share. Many will...
-
536AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) Is Already Rewarding Our Readers
Back on July 6, we highlighted AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) as one to watch in our Biotech Catalyst series. The company was...
-
587Here’s What’s Behind The BioLife Solutions Inc (NASDAQ:BLFS) Run And What It Means Going Forward
It’s only been two weeks since we covered BioLife Solutions Inc (NASDAQ:BLFS) here, detailing the company’s then-latest announcement and putting forward what...
-
571Is HTG Molecular Diagnostics Inc (NASDAQ:HTGM) Finally Starting To Turn Around?
For the past six months we’ve repeatedly suggested that HTG Molecular Diagnostics Inc (NASDAQ:HTGM) is undervalued and should be in line for...